TRUVENTIN Trademark

Trademark Overview

On Wednesday, May 15, 2002, a trademark application was filed for TRUVENTIN with the United States Patent and Trademark Office. The USPTO has given the TRUVENTIN trademark a serial number of 76408154. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, October 1, 2006. This trademark is owned by GENENTECH, INC.. The TRUVENTIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, or inflammatory diseases and disorders
truventin

General Information

Serial Number76408154
Word MarkTRUVENTIN
Filing DateWednesday, May 15, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, October 1, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 8, 2003

Trademark Statements

Goods and ServicesPharmaceuticals, namely, preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, or inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 17, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Trademark Events

Event DateEvent Description
Friday, December 8, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, December 8, 2006ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 19, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2006EXTENSION 5 GRANTED
Wednesday, March 29, 2006EXTENSION 5 FILED
Wednesday, March 29, 2006TEAS EXTENSION RECEIVED
Wednesday, September 14, 2005EXTENSION 4 GRANTED
Wednesday, September 14, 2005EXTENSION 4 FILED
Wednesday, September 14, 2005TEAS EXTENSION RECEIVED
Monday, April 18, 2005EXTENSION 3 GRANTED
Wednesday, March 23, 2005EXTENSION 3 FILED
Wednesday, March 23, 2005TEAS EXTENSION RECEIVED
Friday, February 18, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 31, 2004EXTENSION 2 GRANTED
Tuesday, August 31, 2004EXTENSION 2 FILED
Tuesday, August 31, 2004TEAS EXTENSION RECEIVED
Thursday, August 19, 2004CASE FILE IN TICRS
Monday, July 5, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 24, 2004EXTENSION 1 GRANTED
Tuesday, March 9, 2004EXTENSION 1 FILED
Tuesday, March 9, 2004TEAS EXTENSION RECEIVED
Tuesday, September 30, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 8, 2003PUBLISHED FOR OPPOSITION
Wednesday, June 18, 2003NOTICE OF PUBLICATION
Tuesday, May 13, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 21, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 21, 2003PAPER RECEIVED
Friday, January 3, 2003ASSIGNED TO EXAMINER
Thursday, October 17, 2002NON-FINAL ACTION MAILED
Wednesday, October 16, 2002ASSIGNED TO EXAMINER
Monday, September 9, 2002ASSIGNED TO EXAMINER
Wednesday, September 4, 2002ASSIGNED TO EXAMINER

Related Keywords

truventin disorders diseases immune angiogenesis ocular inflammatory oncological namely treatment cardiovascular